[go: up one dir, main page]

DK106685A - Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf - Google Patents

Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK106685A
DK106685A DK106685A DK106685A DK106685A DK 106685 A DK106685 A DK 106685A DK 106685 A DK106685 A DK 106685A DK 106685 A DK106685 A DK 106685A DK 106685 A DK106685 A DK 106685A
Authority
DK
Denmark
Prior art keywords
preparing
procedure
active substance
controlled delivery
delivery
Prior art date
Application number
DK106685A
Other languages
English (en)
Other versions
DK169421B1 (da
DK106685D0 (da
Inventor
Tsutomu Irikura
Hiroshi Uchida
Jun Imai
Masakatsu Komuro
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of DK106685D0 publication Critical patent/DK106685D0/da
Publication of DK106685A publication Critical patent/DK106685A/da
Application granted granted Critical
Publication of DK169421B1 publication Critical patent/DK169421B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK106685A 1984-03-14 1985-03-08 Farmaceutisk præparat til oral indgift med kontrolleret afgivelse DK169421B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59048441A JPH0621066B2 (ja) 1984-03-14 1984-03-14 ３―イソブチリル―２―イソプロピルピラゾロ〔１，５―ａ〕ピリジンの徐放性医薬品組成物
JP4844184 1984-03-14

Publications (3)

Publication Number Publication Date
DK106685D0 DK106685D0 (da) 1985-03-08
DK106685A true DK106685A (da) 1985-09-15
DK169421B1 DK169421B1 (da) 1994-10-31

Family

ID=12803438

Family Applications (2)

Application Number Title Priority Date Filing Date
DK106685A DK169421B1 (da) 1984-03-14 1985-03-08 Farmaceutisk præparat til oral indgift med kontrolleret afgivelse
DK057993A DK169096B1 (da) 1984-03-14 1993-05-18 Rektalt suppositorie med kontrolleret afgivelse af virksomt stof og fremgangsmåde til fremstilling heraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK057993A DK169096B1 (da) 1984-03-14 1993-05-18 Rektalt suppositorie med kontrolleret afgivelse af virksomt stof og fremgangsmåde til fremstilling heraf

Country Status (11)

Country Link
US (1) US5151434A (da)
EP (2) EP0156243B1 (da)
JP (1) JPH0621066B2 (da)
KR (1) KR850006130A (da)
AU (1) AU582739B2 (da)
DE (2) DE3580774D1 (da)
DK (2) DK169421B1 (da)
IE (1) IE57853B1 (da)
NZ (1) NZ211424A (da)
PH (1) PH21996A (da)
ZA (1) ZA851830B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤
JPH01153633A (ja) 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd 経皮吸収製剤
JPH01153634A (ja) * 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd 吸入剤
US5213800A (en) * 1989-02-09 1993-05-25 Diamond Scientific Company Chlorhexidine disinfectant granules
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
US8293277B2 (en) 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
WO2000018374A1 (en) * 1998-10-01 2000-04-06 Elan Pharma International, Ltd. Controlled release nanoparticulate compositions
US8236352B2 (en) 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
US6720356B2 (en) * 2001-04-20 2004-04-13 Spencer Feldman Magnesium di-potassium EDTA complex and method of administration
CA2475092C (en) 2002-02-04 2012-05-01 Christian F. Wertz Nanoparticulate compositions having lysozyme as a surface stabilizer
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
JP5352452B2 (ja) * 2006-06-06 2013-11-27 メディシノバ， インコーポレイテッド 置換ピラゾロ［１，５−ａ］ピリジン化合物およびその使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784683A (en) * 1971-03-29 1974-01-08 Abbott Lab Tablet preparation
JPS5229318B2 (da) * 1972-03-30 1977-08-01
JPS5229318A (en) * 1975-09-01 1977-03-05 Nippon Telegraph & Telephone Type head for high speed printer or the like
CA1188505A (en) * 1982-08-24 1985-06-11 Kenneth L. Hurley Toner feeder system
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤

Also Published As

Publication number Publication date
JPS60193913A (ja) 1985-10-02
NZ211424A (en) 1988-09-29
DK57993A (da) 1993-05-18
AU582739B2 (en) 1989-04-13
EP0156243B1 (en) 1990-12-05
DK169421B1 (da) 1994-10-31
PH21996A (en) 1988-05-02
JPH0621066B2 (ja) 1994-03-23
DE3580774D1 (de) 1991-01-17
KR850006130A (ko) 1985-10-02
EP0156243A2 (en) 1985-10-02
DK106685D0 (da) 1985-03-08
DK169096B1 (da) 1994-08-15
US5151434A (en) 1992-09-29
IE57853B1 (en) 1993-04-21
IE850593L (en) 1985-09-14
ZA851830B (en) 1985-11-27
EP0375662A3 (en) 1990-11-07
DK57993D0 (da) 1993-05-18
EP0375662A2 (en) 1990-06-27
DE156243T1 (de) 1986-05-22
AU3967685A (en) 1985-09-19
EP0156243A3 (en) 1987-03-25

Similar Documents

Publication Publication Date Title
DK158032C (da) Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat
DK616986A (da) Saarplejemiddel indeholdende et aktivt stof til fremme af saarbehandlingen og fremgangsmaade til fremstilling deraf
DK606086D0 (da) Transdermalt eller dermalt plaster til indgift af en kontrolleret maengde aktivt stof
DK208685D0 (da) Apparat til afgivelse af flygtigt aktivt stof
DK243286A (da) Fremstilling af system til afgivelse af aktive bestanddele
DK106685A (da) Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf
DK28985D0 (da) Stabilt humant gamma-interferonpraeparat samt fremgangsmaade til fremstilling deraf
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
DK386287D0 (da) Anvendelse af et hydrofobt stof til fremstilling af et enterisk praeparat til behandling af fedme samt enteriske praeparater
DK88183D0 (da) Biokemisk aktivt stof, fremgangsmade til fremstilling heraf samt midler med indhold af stoffet
DK164149C (da) Fremgangsmaade til fremstilling af et praeparat indeholdende methylhydroxyprogesteronacetat samt farmaceutisk praeparat indeholdende stoffet
DK537685A (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
DK18179A (da) 2-pyrrolidon-forbindelser og fremgangsmaade til deres fremstilling samt deres anvendelse til fremstilling af farmakologisk aktive forbindelser
DK284585A (da) 1,4-dihydropyrinderivater, fremgangsmaade til fremstilling af saadanne forbindelser samt laegemiddel indeholdende disse
DK160280C (da) 4'-deschlorrebeccamycin, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat indeholdende det
DK382785D0 (da) Alfa-(o-chlorphenyl)-aminomethylen-beta-formylaminopropionitril, fremgangsmaade til fremstilling af dette samt anvendelse af dette til fremstilling af 2-methyl-4-amino-5-formylaminomethyl-pyrimidin
DK6181A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater i tabletform med langvarig afgivelse af det virksomme stof
DK173686D0 (da) Heterocykliske forbindelser samt fremgangsmaade til fremstilling heraf
FI903418A7 (fi) Stabiloidut juoksevat herbisidivalmisteet
DK38493D0 (da) Fremgangsmaade til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
DK115685A (da) Prespap samt fremgangsmaade til fremstilling deraf
DK464686D0 (da) Praeparat med kontrolleret afgivelse af det aktive stof
DK219985A (da) Fremgangsmaade til fremstilling af kiselsyrerige poroese formlegemer samt deres anvendelse
DK150482A (da) Fremgangsmaade til fremstilling af formlegemer af polylaurinlaktam samt de derved fremstillede formlegemer
DK163980A (da) Fremgangsmaade til fremstilling af et biologisk aktivt stof 41.200rp med immunstimulerende virkning

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired